Cordis US Executive and Leadership Team

Duke Rohlen, the Chief Executive Officer at Cordis US, directs the overarching strategic vision for the global medical-device organization. By prioritizing the development of advanced guidewires, catheters, and stents, the Chief Executive Officer ensures the company maintains a competitive edge in treating coronary and peripheral vascular diseases. Duke Rohlen manages high-level interactions with the Board to align long-term growth objectives with current market demands. This leadership role involves overseeing the integration of new interventional cardiovascular technologies into the existing product portfolio. Through rigorous assessment of operational efficiency, the Chief Executive Officer drives the company toward sustainable profitability. By fostering a culture of innovation, Rohlen secures the future of the enterprise. The Chief Executive Officer maintains a focus on expanding the reach of minimally invasive solutions across international markets, ensuring that the organization remains a leader in the medical manufacturing sector while delivering consistent value to stakeholders and patients alike.

Hernan Domenico, the Chief Financial Officer & Head of Finance (Americas) at Cordis US, manages the fiscal health and capital allocation strategies for the organization. Overseeing financial planning and analysis across the Americas, the Chief Financial Officer & Head of Finance (Americas) ensures that resource distribution supports the manufacturing of critical vascular closure systems and balloons. Hernan Domenico coordinates with regional leadership to optimize budgetary performance and mitigate financial risks associated with global supply chains. This role involves rigorous oversight of revenue streams and cost-management initiatives to bolster the company's market position. By implementing robust financial controls, the Chief Financial Officer & Head of Finance (Americas) provides the necessary stability for ongoing research and development efforts. Domenico drives the financial strategy that enables the company to scale production capabilities effectively. Through precise fiscal management, the Chief Financial Officer & Head of Finance (Americas) supports the long-term viability of the business model in a complex, highly regulated medical device landscape.

Bryan Loo, the President, Asia Pacific at Cordis US, directs all commercial operations and market penetration strategies throughout the Asia Pacific region. By overseeing the distribution of catheters, stents, and vascular closure systems, the President, Asia Pacific ensures that the company meets the specific clinical needs of regional healthcare providers. Bryan Loo manages local partnerships and regulatory compliance efforts to facilitate the adoption of minimally invasive cardiovascular technologies. This leadership role involves analyzing regional market trends to identify growth opportunities and optimize the supply chain for local delivery. By driving sales performance and clinical education initiatives, the President, Asia Pacific strengthens the company's footprint in emerging markets. Loo coordinates with global headquarters to ensure that regional strategies align with the broader corporate mission. Through effective management of regional teams, the President, Asia Pacific secures a dominant market position, ensuring that the company remains the preferred provider for cardiovascular solutions across the diverse and rapidly expanding Asia Pacific healthcare landscape.

Matthew Muscari, the President, Americas at Cordis US, executes the commercial strategy and operational growth plans for the North and South American markets. By overseeing the sales and distribution of guidewires, balloons, and other interventional devices, the President, Americas ensures that the company maintains high service levels for hospitals and clinics. Matthew Muscari manages regional sales teams and clinical support staff to drive the adoption of advanced cardiovascular technologies. This role involves identifying key market segments and tailoring product offerings to address specific regional vascular disease challenges. By optimizing the regional supply chain and distribution network, the President, Americas enhances operational efficiency and customer satisfaction. Muscari collaborates with the executive team to integrate new product launches into the Americas market effectively. Through consistent focus on revenue growth and market share expansion, the President, Americas supports the overall corporate objective of delivering life-saving medical devices to patients throughout the Western Hemisphere.

Nancy Pounder, the Chief Human Resources Officer at Cordis US, architects the talent acquisition and organizational development strategies necessary to support a global medical-device workforce. By aligning human capital initiatives with the company's mission to manufacture advanced cardiovascular devices, the Chief Human Resources Officer ensures that the organization attracts top-tier engineering and clinical expertise. Nancy Pounder manages performance management systems and leadership development programs that foster a culture of excellence. This role involves collaborating with other C-suite leaders to implement structural changes that enhance operational agility. By optimizing employee engagement and retention, the Chief Human Resources Officer drives the internal capabilities required to sustain innovation in minimally invasive technologies. Pounder oversees the implementation of corporate policies that promote a safe and inclusive work environment across all manufacturing facilities. Through strategic workforce planning, the Chief Human Resources Officer ensures that the company possesses the human resources needed to meet the evolving demands of the global cardiovascular market.